Navigation Links
Dr. Jonathan Zaidan MD and Debbie Henry NP-C Collaborate to Provide Pelvic Pain Management at Women’s Excellence in Endometriosis near Rochester, MI
Date:1/18/2013

Rochester, MI (PRWEB) January 18, 2013

For over a decade, Dr. Jonathan Zaidan MD has been treating women with endometriosis and chronic pelvic pain (CPP). Over those years, he has established himself as an expert in diagnosing and treating endometriosis. Dr. Zaidan has been trained and credentialed in the latest therapy to treat endometriosis: the minimally-invasive Da Vinci Robotic surgery. Robotic resection of endometriosis has given women who suffer with the disease a treatment that significantly improves their quality of life. The fact that the procedure is “minimally invasive” means that incisions are smaller, hospital stays shorter, and recovery time much quicker. According to Dr. Zaidan, “Robotic resection of endometriosis is the most advanced treatment for the disease and can even provide a surgical cure for some individuals”.

At Women’s Excellence in Endometriosis, the Da Vinci Robotic procedure to remove endometriosis is usually preceded by a 6-month course of Zoladex (goserelin) or Lupron (leuprolide) therapy. Both Zoladex and Lupron are classified as gonadotropin-releasing hormone superagonists (GnRH agonists). Both agents stimulate an overproduction of sex hormones resulting in the decrease of both estrogen and testosterone over time. The purpose of this therapy is to allow the body a rest from menstrual cycles and periods thought to cause endometriosis implants throughout the pelvic cavity. The therapy ultimately inhibits the production of estrogen, which is thought to “feed” the disease. Patients are usually required to commit to a monthly dosing of either therapy and are typically scheduled for the robotic procedure sometime after their 6th dose.

Although GnRH agonist therapy has shown to be effective in helping limit the progression of endometriosis, it is a difficult therapy for patients to tolerate due to all the menopausal side effects. “Patient compliance with therapy was becoming a huge issue. The first month is usually the worst and most patients abandon ship and then never make it to the final and most important treatment phase: the surgery. I knew I needed some help in supporting the patients during the medical therapy phase”, stated Dr. Zaidan. For this reason, Dr. Zaidan has collaborated with Debbie Henry, NP-C, to ensure patients complete a 6-month course of therapy and actually make it to the robotic procedure.

Debbie Henry, NP-C, was hired by Dr. Zaidan in 2008 and has been a major factor in the success of the endometriosis treatment at Women’s Excellence in Endometriosis, According Henry, “My job is to support these patients during their Zoladex or Lupron therapy physically and mentally”. According to Henry, most women experience significant menopausal side effects from the therapy and need support usually in the form of hormonal add-back therapy, anti-depressant therapy, and pain management. With the addition of Henry to Women’s Excellence in Endometriosis, most patients now successfully complete treatment and move on to the robotic procedure giving them a chance at the best possible outcome.

Founded by Dr. Jonathan Zaidan, Women's Excellence in Endometriosis is a comprehensive center for women that have either been diagnosed with endometriosis or have the symptoms of endometriosis. Women’s Excellence in Endometriosis utilizes the latest and best treatment protocols to effectively treat the symptoms and sequelae of endometriosis. Whether a woman has known endometriosis or seeking a diagnosis for symptoms of painful intercourse, painful periods, chronic pelvic pain or irregular bleeding, Women's Excellence in Endometriosis is designed to diagnose, treat and improve the symptoms of endometriosis and chronic pelvic pain (CPP). Women’s Excellence in Endometriosis treats all women with these symptoms including those women in the teenage years, women who are desiring having a child, as well as women who are done with their childbearing. The knowledgeable, well trained, compassionate physicians and healthcare providers of Women’s Excellence in Endometriosis are now accepting new patients. Call for an appointment today (248) 693-1630 or visit http://www.centerofendometriosis.com.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10321354.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dr. Jonathan Lass to be honored by Eye Bank Association of America
2. Implant Overdentures - Dr. Jonathan Penchas Has Examined Studies That Show a High Success Rate and Advantages over Long Period
3. ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton Medal
4. AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases
5. Journals and pharma collaborate on new recommendations
6. ICA Fellow, Dafna Lemish, collaborates with UNICEF on child development initiative
7. Springer and the Breast Cancer Research Foundation to collaborate on book series
8. ACP and WellPoint collaborate to give physicians the tools they need to participate in PCMH programs
9. CWRU dental and nursing students collaborate for one-stop healthcare
10. Organizations collaborate to support research on arthritis and aging
11. ACP and NACHC collaborate to help federally-qualified heath centers improve care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: